Skip to main content
PMC home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1983 Dec;36(12):1377–1381. doi: 10.1136/jcp.36.12.1377

Fibronectin in blood products--an in vitro and in vivo study.

J T Reilly, B A McVerry, M J Mackie
PMCID: PMC498572  PMID: 6418769

Abstract

The concentration of fibronectin was assessed in a variety of coagulation factor preparations. Highest concentrations of fibronectin were found in the intermediate purity factor VIII concentrates. Significant amounts were found in cryoprecipitate but high purity factor VIII concentrates contained only small amounts. For practical purposes factor IX concentrates contained no fibronectin. Qualitative estimation of fibronectin showed the presence of an abnormal slow migrating peak on 2 DIEP which was not found in normal plasma. In vivo recovery infused fibronectin was relatively low for all products studied (30-54%). The plasma half life (17-25 h) did not differ significantly depending on whether cryoprecipitate or a factor VIII concentrate was used as a source of fibronectin. No enhancement of plasma fibronectin concentrations was obtained following DDAVP infusion, venous occlusion and exercise. Plasma fibronectin concentrations and 2 DIEP patterns were unaltered following prolonged storage.

Full text

PDF
1377

Images in this article

1379Image
on p.1379

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allain J. P., Verroust F., Soulier J. P. In vitro and in vivo characterization of factor VIII preparations. Vox Sang. 1980 Feb;38(2):68–80. doi: 10.1111/j.1423-0410.1980.tb02333.x. [DOI] [PubMed] [Google Scholar]
  2. Aronsen K. F., Ekelund G., Kindmark C. O., Laurell C. B. Sequential changes of plasma proteins after surgical trauma. Scand J Clin Lab Invest Suppl. 1972;124:127–136. doi: 10.3109/00365517209102760. [DOI] [PubMed] [Google Scholar]
  3. Boughton B. J., Simpson A. Plasma fibronectin in acute leukaemia. Br J Haematol. 1982 Jul;51(3):487–491. doi: 10.1111/j.1365-2141.1982.tb02806.x. [DOI] [PubMed] [Google Scholar]
  4. Dagher F. J., Lyons J. H., Finlayson D. C., Shamsai J., Moore F. D. Blood volume measurement: a critical study prediction of normal values: controlled measurement of sequential changes: choice of a bedside method. Adv Surg. 1965;1:69–109. [PubMed] [Google Scholar]
  5. Engvall E., Ruoslahti E. Binding of soluble form of fibroblast surface protein, fibronectin, to collagen. Int J Cancer. 1977 Jul 15;20(1):1–5. doi: 10.1002/ijc.2910200102. [DOI] [PubMed] [Google Scholar]
  6. Kaplan J. E., Saba T. M. Low-grade intravascular coagulation and reticuloendothelial function. Am J Physiol. 1978 Apr;234(4):H323–H329. doi: 10.1152/ajpheart.1978.234.4.H323. [DOI] [PubMed] [Google Scholar]
  7. Klingemann H. G., Kosukavak M., Höfeler H., Havemann K. Fibronectin and factor VIII-related antigen in acute leukaemia. Hoppe Seylers Z Physiol Chem. 1983 Mar;364(3):269–277. doi: 10.1515/bchm2.1983.364.1.269. [DOI] [PubMed] [Google Scholar]
  8. Lanser M. E., Saba T. M. Opsonic fibronectin deficiency and sepsis. Cause or effect? Ann Surg. 1982 Mar;195(3):340–345. doi: 10.1097/00000658-198203000-00015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Lanser M. E., Saba T. M., Scovill W. A. Opsonic glycoprotein (plasma fibronectin) levels after burn injury. Relationship to extent of burn and development of sepsis. Ann Surg. 1980 Dec;192(6):776–782. doi: 10.1097/00000658-198012000-00014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Laurell C. B. Electroimmuno assay. Scand J Clin Lab Invest Suppl. 1972;124:21–37. doi: 10.3109/00365517209102748. [DOI] [PubMed] [Google Scholar]
  11. Levine P. H., McVerry B. A., Attock B., Dormandy K. M. Health of the intensively treated hemophiliac, with special reference to abnormal liver chemistries and splenomegaly. Blood. 1977 Jul;50(1):1–9. [PubMed] [Google Scholar]
  12. Mosher D. F., Williams E. M. Fibronectin concentration is decreased in plasma of severely ill patients with disseminated intravascular coagulation. J Lab Clin Med. 1978 May;91(5):729–735. [PubMed] [Google Scholar]
  13. Nilsson I. M., Walter H., Mikaelsson M., Vilhardt H. Factor VIII concentrate prepared from DDAVP stimulated blood donor plasma. Scand J Haematol. 1979 Jan;22(1):42–46. doi: 10.1111/j.1600-0609.1979.tb00398.x. [DOI] [PubMed] [Google Scholar]
  14. Ragni M. V., Lewis J. H., Spero J. A., Bontempo F. A. Acquired-immunodeficiency-like syndrome in two haemophiliacs. Lancet. 1983 Jan 29;1(8318):213–214. doi: 10.1016/s0140-6736(83)92589-8. [DOI] [PubMed] [Google Scholar]
  15. Saba T. M., Blumenstock F. A., Scovill W. A., Bernard H. Cryoprecipitate reversal of opsonic alpha2-surface binding glycoprotein deficiency in septic surgical and trauma patients. Science. 1978 Aug 18;201(4356):622–624. doi: 10.1126/science.675246. [DOI] [PubMed] [Google Scholar]
  16. Saba T. M., Jaffe E. Plasma fibronectin (opsonic glycoprotein): its synthesis by vascular endothelial cells and role in cardiopulmonary integrity after trauma as related to reticuloendothelial function. Am J Med. 1980 Apr;68(4):577–594. doi: 10.1016/0002-9343(80)90310-1. [DOI] [PubMed] [Google Scholar]
  17. Scott R. L., Sohmer P. R., MacDonald M. G. The effect of starvation and repletion on plasma fibronectin in man. JAMA. 1982 Oct 22;248(16):2025–2027. [PubMed] [Google Scholar]
  18. Scovill W. A., Saba T. M., Kaplan J. E., Bernard H. R., Powers S. R., Jr Disturbances in circulating opsonic activity in man after operative and blunt trauma. J Surg Res. 1977 Jun;22(6):709–716. doi: 10.1016/0022-4804(77)90113-5. [DOI] [PubMed] [Google Scholar]
  19. Scovill W. A., Saba T. M., Kaplan J. E., Bernard H., Powers S., Jr Deficits in reticuloendothelial humoral control mechanisms in patients after trauma. J Trauma. 1976 Nov;16(11):898–904. doi: 10.1097/00005373-197611000-00008. [DOI] [PubMed] [Google Scholar]
  20. Sherman L. A., Lee J. Fibronectin: blood turnover in normal animals and during intravascular coagulation. Blood. 1982 Sep;60(3):558–563. [PubMed] [Google Scholar]
  21. Stathakis N. E., Fountas A., Tsianos E. Plasma fibronectin in normal subjects and in various disease states. J Clin Pathol. 1981 May;34(5):504–508. doi: 10.1136/jcp.34.5.504. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Weber K., Osborn M. The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis. J Biol Chem. 1969 Aug 25;244(16):4406–4412. [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES